Novazyme Pharmaceuticals
Latest round
- Series A
Last raised
- Sep 2000
Total raised
- $8M
Investors
- 3
About Novazyme Pharmaceuticals
Novazyme Pharmaceuticals develops bio therapeutic products for the treatment of lysosomal storage disorders.
Who invested in Novazyme Pharmaceuticals
3 investors across 1 round
See all investors in Novazyme Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 19, 2000
Amount
$8M
Investors
Questions about Novazyme Pharmaceuticals
Who invested in Novazyme Pharmaceuticals?
Novazyme Pharmaceuticals has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Novazyme Pharmaceuticals raised?
Novazyme Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Novazyme Pharmaceuticals last raise money?
Novazyme Pharmaceuticals's most recent round on record is a Series A, in Sep 2000.
What does Novazyme Pharmaceuticals do?
Novazyme Pharmaceuticals develops bio therapeutic products for the treatment of lysosomal storage disorders.
Where is Novazyme Pharmaceuticals headquartered?
Novazyme Pharmaceuticals is headquartered in Princeton, US.
Which VCs invest in companies like Novazyme Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Novazyme Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Novazyme Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.